NCT00044824 - Efficacy and Safety of Fexofenadine in Mild to Moderate Persistent Asthma | Biotech Hunter

Enrollment

1,000

Participants

Timeline

Start Date

February 28, 2002

Primary Completion Date

October 31, 2003

Study Completion Date

October 31, 2003

Conditions

Asthma

Interventions

DRUG

Fexofenadine

Trial Locations (7)

Aventis Pharmaceuticals Inc., Bridgewater

Sanofi-Aventis Admnistrative Office, Costa Rica

Sanofi-Aventis Administrative Office, Guatemala City

sanofi-aventis Hungaria, Budapest

Sanofi-Aventis Administrative Office, México

sanofi-aventis Poland, Warsaw

Sanofi-Aventis Aministrative Office, Moscow